Another study showed that semaglutide protected against A 25-35 in SH-SY5Y cells by enhancing autophagy (200)
Cutting corners with research-grade GLP-1s may seem convenient, but it exposes clinics to unnecessary risk and undermines patient trust
The frustrating reality is that two people with identical BMIs, identical health conditions, and identical GLP-1 prescriptions can receive completely different coverage decisions based solely on which insurance company they happen to have
On the flip side, inadequate protein intake can increase the risk of falls and fractures, surgical complications, and reduced quality of life, among other adverse health outcomes
There are illegal online pharmacies selling GLP-1 medications and those medications are not checked for safety
What is the biggest risk of taking both together